NCT06601803

Brief Summary

Bacteria is occasionally present in the shoulder during shoulder arthroplasty surgery and is hypothesized to increase the risk of failure of the prosthesis. Surgiphor (sterile Povidone-Iodine) wound irrigation, is a solution used in orthopaedic surgery and other surgical fields to kill bacteria intraoperatively. The Iodine dissociates from complex and has antimicrobial properties, causing cell death of bacteria, fungi, and viruses through interactions with proteins, nucleotides, and fatty acids in the cytoplasm and cytoplasmic membrane. This study examines the use of Povidone-Iodine during primary shoulder arthroplasty.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
126

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2024

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

September 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1 year

First QC Date

September 16, 2024

Last Update Submit

September 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction or elimination of bacteria

    To determine the rate of reduction of positive cultures collected before and after wound irrigation with either Surgiphor or sterile normal saline during primary total shoulder arthroplasty participants will be followed to watch for clinical signs of infection.

    90 days

Study Arms (2)

Total Shoulder Arthroplasty washed with Saline

ACTIVE COMPARATOR

This arm will consist of sterile normal saline to be used before and after placement of shoulder arthroplasty components

Drug: sterile saline solutionProcedure: Sample Collection

Total Shoulder Arthroplasty washed with Surgiphor (Povidone Iodine)

ACTIVE COMPARATOR

This arm will consist of Surgiphor to be used before and after placement of shoulder arthroplasty components

Drug: SurgiphorProcedure: Sample Collection

Interventions

The shoulder will be washed with normal sterile saline before and after placing the shoulder implant

Total Shoulder Arthroplasty washed with Saline

The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant

Total Shoulder Arthroplasty washed with Surgiphor (Povidone Iodine)

During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure

Total Shoulder Arthroplasty washed with SalineTotal Shoulder Arthroplasty washed with Surgiphor (Povidone Iodine)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults age \>18 years
  • Participants undergoing elective primary total shoulder arthroplasty
  • Participants willing to provide written consent

You may not qualify if:

  • History of prior surgery to the operative shoulder
  • Known allergy to povidone iodine, iodine or shellfish
  • active clinical infection
  • participation in other clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rothman Orthopaedic Institute

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Interventions

Specimen Handling

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 19, 2024

Study Start

September 16, 2024

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations